Centura Medical Group Urology
​
8200 E. Belleview Ave. Suite 100E | Greenwood Village, CO 80111
P: 303-649-3710 F: 303-649-3711
Treatment Information
Dr. Wilson loves helping patients with urological cancers, however she specializes in treating patients suffering from bladder cancer. There are various types and stages of bladder cancer and many of those types result in cystectomy, or bladder removal. After the bladder is removed, you and Dr. Wilson can work together to decide which of the three types of diversions will work best for your type of cancer and life style. The first type of diversion is an ileal conduit, which utilizes a portion of the intestine to serve as a passageway for urine from the ureters to a stoma. The second type of diversion is the continent cutaneous diversions (Indiana pouch), which utilizes a portion of the intestine to create a pouch to hold urine until it can be released through the stoma. The third type of diversion is the Orthotopic Neobladder, which utilizes a portion of the small intestine to replace the urinary bladder.
​
​
In addition to bladder cancer, Dr. Wilson also treats complex cases of kidney cancer as well as the rare occurrences of penile cancer, and testicular cancer.
​
For her male patients who undergo radiation treatment for prostate cancer, she uses SpaceOAR Hydrogel. It acts as a spacer providing space between the rectum and the prostate, reducing radiation exposure to the rectum. It is injected into place prior to the start of radiation treatment. Patients may be awake or asleep under general anesthesia for the procedure. SpaceOAR Hydrogel remains stable during radiation therapy and then is gradually absorbed by the body after radiation therapy has been completed.
Prior to cystectomy and diversion, chemotherapy is administered in patients with invasive bladder cancers. This approach in conjunction with improvements in surgical techniques as well as better alternatives to bladder removal in select patients has resulted in cancer-specific survival improvement in patients with invasive bladder cancer from 50% to over 80% within Dr. Wilsons years of practice.
